Is Laryngeal Ultrasound Useful in the Assessment for ILO? A Protocol for a Two-stage Exploratory Pilot Study
Launched by LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST · Jan 13, 2023
Trial Information
Current as of November 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether using an ultrasound scan on the vocal cords can help identify a condition called inducible laryngeal obstruction (ILO). In ILO, the vocal cords narrow or close when a person breathes in, which can make it really hard to breathe. The study aims to find out if this ultrasound method is effective for detecting such narrowing in patients who might have breathing difficulties, especially those with conditions like vocal cord dysfunction or asthma.
To participate in the study, you must be a healthy adult aged between 65 and 74, with no signs of vocal cord issues, voice changes, or a history of throat surgeries. If you have any known vocal cord problems or have had surgeries in the head or neck area, you won't be eligible. If you decide to join, you can expect to undergo a simple ultrasound scan of your vocal cords, which is painless and quick. This study is currently recruiting participants, and your involvement could help improve how doctors assess breathing issues related to the vocal cords in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Healthy volunteers:
- • No definite signs or symptoms of vocal fold paralysis
- • No voice change
- • No history laryngeal surgeries
- • No History of pathology
- • No uncontrolled Respiratory disease
- Exclusion Criteria:
- • Participants with a known vocal fold pathology
- • Participants with a history of head and neck surgery.
About Lancashire Teaching Hospitals Nhs Foundation Trust
Lancashire Teaching Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to delivering high-quality clinical services and advancing medical research. As a prominent sponsor of clinical trials, the Trust is committed to improving patient outcomes through innovative research and evidence-based practices. With a focus on collaboration and patient-centered care, it fosters an environment where multidisciplinary teams work together to explore new treatments and enhance healthcare delivery. The Trust's robust infrastructure and expertise enable it to conduct a wide range of clinical studies, contributing to the advancement of medical knowledge and the development of effective therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Preston, Lancashire, United Kingdom
Patients applied
Trial Officials
Kina Bennett
Study Chair
Lancashire Teaching Hospitals NHS Trust
Claire Slinger
Principal Investigator
Lancashire Teaching Hospitals NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials